Khiron Life Sciences Corp KHRNKHRNF, a vertically integrated cannabis company with core operations in Latin America, announced its intention to deliver the company's Kuida® CBD brand to the Spanish market.
This follows the reception of a "no objection" letter from the TSXV specific to Spain and is subject to meeting all regulatory approvals of the Spanish country. According to Euromonitor, Khiron plans to commercialize Kuida to a combined skincare market of over $6 billion.
"As our European operations ramp up, we are able to bring our unique products, consumer experience and scientific capabilities from Latin America into one of the world's fastest growing markets. Entry for our Kuida brand into Spain, and later Switzerland, will represent another milestone in the Company's strategy to serve consumers across multiple categories and markets," said Tejinder Virk, President, Khiron Europe.
Kuida, the prime consumer brand of Khiron's wellness business unit, carries the benefits of CBD to a product portfolio of skin and body care products. Kuida was nationally launched in October 2018. Available through retail, wholesale and online e-commerce channels.
As the company increases Kuida distribution in Europe, an initial launch in the U.K. will be succeeded by a strategic marketing and retail campaign.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.